DOES POOR BLASTOCYST MORPHOLOGY IMLPY LOWER EUPLOIDY RATE IN PATIENTS UNDERGOING PGT-A?

Shujing He,Lei Jia,Wenlong Su,Cong Fang
DOI: https://doi.org/10.1016/j.fertnstert.2020.08.1265
IF: 6.7
2020-01-01
Fertility and Sterility
Abstract:The aim of this study is to figure out whether poor blastocyst morphology implies lower euploidy rate and whether blastocysts of low morphological scores deserve to be performed trophectoderm (TE) biopsy. This is a single center retrospective observational study performed between June 2018 and April 2020. The study included the data analysis of 798 blastocysts from 197 couples undergoing preimplantation genetic testing for aneuploidies (PGT-A) via next generation sequencing. According to the patients’ chromosome karyotype, blastocysts were divided into two groups: preimplantation genetic screening (PGS, patients with normal chromosome karyotype) and preimplantation genetic diagnosis (PGD, patients with chromosomal rearrangements). According to the Gardner grading system, the morphological score of good quality blastocyst was ≥3BB, and that of poor quality blastocyst was <3BB (including 3BC, 3AC, 4BC, 4CB, 4CA and 4AC). We also analyzed the impact of maternal age by dividing female into young group (age<35) and old group (age≥35). Chi-square test was used to assess differences. All statistical analysis was performed using SPSS 22.0. P <0.05 were considered to be statistically significant. Euploidy rate in total PGT-A was 41.2% (259/628) and 28.2% (48/170) in good and poor quality blastocyst groups, respectively (P<0.01). In PGD group, euploidy rate was 37.1% (159/429) and 18.9% (18/95) in good and poor quality blastocyst groups (P<0.01), which indicated that blastocyst morphology was significantly associated with genetic condition (euploidy or aneuploidy). Whereas, there was no statistical differences in PGS group. For patients undergoing PGS, euploidy rate was 50.3% (100/199) and 40.0% (30/75) in good and poor quality blastocyst groups, respectively (P>0.05). When considering maternal age, in young group, there was strong association between blastocyst morphology and euploidy rate. Euploidy rate was 42.5% (211/497) and 29.8% (39/131) in good and poor quality blastocyst groups, respectively in young group (P<0.01). But in old group, euploidy rate was36.6% (48/131) and 23.1% (9/39) in good and poor quality blastocyst groups (P>0.05). Poor blastocyst morphology implied lower euploidy rate in patients undergoing PGD. For patients undergoing PGS, it is worthy to perform trophectoderm (TE) biopsy of blastocysts of low morphological scores. And TE biopsy of poor quality blastocysts may benefit the patients with advanced maternal age.
What problem does this paper attempt to address?